Prelude Capital Management, LLC Teva Pharmaceutical Industries LTD Put Options Transaction History

Prelude Capital Management, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2021 Nov 15, 2021	SELL	$8.38 - $10.18 $2.43 Million - $2.95 Million	-290,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$9.9 - $11.56 $2.84 Million - $3.31 Million	286,600 Added 8429.41%	290,000 $2.44 Million
Q1 2020 May 15, 2020	SELL	$6.69 - $13.45 $281,649 - $566,245	-42,100 Reduced 92.53%	3,400 $31,000
Q2 2019 Aug 14, 2019	SELL	$8.12 - $15.72 $36,540 - $70,740	-4,500 Reduced 9.0%	45,500 $420,000
Q1 2019 May 15, 2019	BUY	$15.58 - $20.01 $779,000 - $1 Million	50,000 New	50,000 $784,000

625

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $25.3B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.